Related Experiment Video
Updated: Aug 15, 2026

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
Published on: May 18, 2016
Plasmodium-encoded murine IL-6 impairs liver stage infection and elicits long-lasting sterilizing immunity
Selma Belhimeur1, Sylvie Briquet2, Roger Peronet1
1Institut Pasteur, Université Paris Cité, CNRS ERL9195 and Inserm U1201, Unité de Biologie des Interactions Hôte Parasites, Paris, France.
Introduction:
Plasmodium sporozoites (SPZ) inoculated by Anopheles mosquitoes into the skin of the mammalian host migrate to the liver before infecting hepatocytes. Previous work demonstrated that early production of IL-6 in the liver is detrimental for the parasite growth, contributing to the acquisition of a long-lasting immune protection after immunization with live attenuated parasites.
Methods:
Considering that IL-6 as a critical pro-inflammatory signal, we explored a novel approach whereby the parasite itself encodes for the murine IL-6 gene. We generated transgenic P. berghei parasites that express murine IL-6 during liver stage development.
Results And Discussion:
Though IL-6 transgenic SPZ developed into exo-erythrocytic forms in hepatocytes in vitro and in vivo, these parasites were not capable of inducing a blood stage infection in mice. Furthermore, immunization of mice with transgenic IL-6-expressing P. berghei SPZ elicited a long-lasting CD8+ T cell-mediated protective immunity against a subsequent infectious SPZ challenge. Collectively, this study demonstrates that parasite-encoded IL-6 attenuates parasite virulence with abortive liver stage of Plasmodium infection, forming the basis of a novel suicide vaccine strategy to elicit protective antimalarial immunity.
Insights
Genetically engineered Plasmodium parasites expressing IL-6 were developed. These parasites failed to cause infection but generated long-lasting protective immunity, suggesting a novel malaria vaccine strategy.
Area of Science:
- Malariology
- Immunology
- Parasitology
Background:
- Plasmodium sporozoites (SPZ) migrate to the liver after mosquito inoculation.
- Early liver-stage IL-6 production is detrimental to parasite growth and aids protective immunity.
Purpose of the Study:
- To investigate the effect of parasite-encoded IL-6 on Plasmodium liver-stage development and host immunity.
- To explore a novel vaccine strategy using genetically modified parasites.
Main Methods:
- Generation of transgenic Plasmodium berghei parasites engineered to express murine IL-6 during the liver stage.
- In vitro and in vivo assessment of parasite development and infectivity in mice.
- Evaluation of immune responses and protective efficacy following immunization with IL-6-expressing SPZ.
Main Results:
- IL-6 transgenic SPZ developed into exo-erythrocytic forms in hepatocytes but did not establish blood-stage infections.
- Immunization with IL-6-expressing P. berghei SPZ induced robust, long-lasting CD8+ T cell-mediated protective immunity against subsequent SPZ challenge.
- Parasite-encoded IL-6 attenuated parasite virulence, leading to abortive liver-stage infections.
Conclusions:
- Parasite-encoded IL-6 acts as a virulence factor that aborts the Plasmodium liver stage.
- This strategy forms the basis for a novel 'suicide vaccine' approach to elicit protective antimalarial immunity.
Related Concept Videos
Symbiosis
Malaria

